文献速递其他结缔组织病

特发性炎性肌病直接与间接费用的分布及变化轨迹

Distribution and trajectory of direct and indirect costs of idiopathic inflammatory myopathies.
PubMed 文献 · Semin Arthritis Rheum · 2021-07-26

门诊、住院和生产力损失是费用增加的主要驱动因素,间接费用占长期社会成本的显著部分。

要点

  • 特发性炎性肌病相关费用在诊断前2年即开始增加,诊断后1年达峰值。
  • 诊断后5年内人均年费用为一般人群的3至5倍。
  • 间接费用是特发性炎性肌病长期社会成本增加的重要部分。

核心结论

  • 特发性炎性肌病诊断后5年内人均年费用为一般人群的3至5倍,且费用在诊断前2年已开始上升、诊断后1年达峰并持续升高。
  • 间接费用对特发性炎性肌病总体费用增加贡献显著。

研究设计与样本

  • 研究基于瑞典国家患者登记库识别2010至2016年新发成人特发性炎性肌病患者673例,并匹配一般人群对照3343名。
  • 随访起点为特发性炎性肌病诊断日期及一般人群对应日期,采用ICD-10编码定义特发性炎性肌病病例,费用基于国家登记数据计算。

主要发现

  • 特发性炎性肌病相关费用在诊断前2年开始增加。
  • 门诊就诊、住院和生产力损失是总体年度疾病相关费用增加的主要组成部分。
  • 间接费用占特发性炎性肌病长期社会成本的显著部分,且工作年龄合并癌症相关特发性炎性肌病者费用最高。

临床怎么用

  • 在特发性炎性肌病病程早期,临床医生和 allied health professionals 应致力于改善功能、减少损伤并解决重返工作的障碍,以减轻相关费用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To estimate the annual direct and indirect costs associated with Idiopathic Inflammatory Myopathies (IIM) over time, including the pre-diagnostic period. METHODS: A cohort of incident adult IIM patients (n = 673) was identified from the Swedish National Patient Register from 2010 to 2016 and matched with general population comparators (n = 3343). Follow-up started at IIM diagnosis and corresponding date in the general population. International Classification of Diseases codes (ICD-10) were used for IIM case definition. Costs were calculated using national register data. RESULTS: The costs related to IIM started to increase 2 years before diagnosis. In the year following diagnosis, the mean annual IIM cost was €21 639 compared to €4816 in the general population. Five years after diagnosis, the mean annual cost in the IIM cohort was €12 796. Outpatient visits, hospitalizations and productivity loss were the components driving the increment in overall annual disease-related expenditures. Indirect costs accounted for a significant portion of IIM long-term societal costs. The highest costs were found in individuals of working age with cancer-associated IIM. CONCLUSIONS: The mean annual costs in IIM were 3 to 5 times higher than in the general population in the 5-year period following diagnosis. These costs started to increase long before diagnosis, were at their peak in the year post-diagnosis and remained elevated thereafter. Indirect costs contributed to a substantial portion of this increment. Early in the IIM disease course, clinicians and allied health professionals should aim to improve function, reduce damage and address barriers to return-to-work to mitigate these costs.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Leclair V, Moshtaghi-Svensson J, Regardt M, et al. Distribution and trajectory of direct and indirect costs of idiopathic inflammatory myopathies. Semin Arthritis Rheum. 2021. PMID: 34407476. doi:10.1016/j.semarthrit.2021.07.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。